Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. März 2026 21:44 ET | Quelle: The Rosen Law Firm PA

ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ENPH

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Enphase Energy, Inc. (NASDAQ: ENPH) between April 22, 2025...
29. März 2026 21:16 ET | Quelle: The Rosen Law Firm PA

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Concorde International Group Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIGL

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Concorde...
29. März 2026 21:11 ET | Quelle: The Rosen Law Firm PA

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between...
29. März 2026 20:58 ET | Quelle: The Rosen Law Firm PA

TCPC IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages BlackRock TCP Capital Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – TCPC

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BlackRock TCP Capital Corp. (NASDAQ: TCPC) between November...
29. März 2026 20:34 ET | Quelle: Major League Fishing

Jacob Wheeler Earns 11th Bass Pro Tour Win at Suzuki Marine Stage 4 Presented by Plano

EARLY, Texas, March 29, 2026 (GLOBE NEWSWIRE) -- Throughout the first two days of Suzuki Marine Stage 4 Presented by Plano, Jacob Wheeler worried that every scorable bass he caught hampered his...
29. März 2026 20:07 ET | Quelle: The Rosen Law Firm PA

RR DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Richtech Robotics Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 3 Deadline in Securities Class Action Commenced by the Firm – RR

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Richtech Robotics Inc. (NASDAQ: RR) between January 27,...
29. März 2026 20:06 ET | Quelle: The Rosen Law Firm PA

MASONITE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Masonite International Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DOOR

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of Masonite International Corporation (NYSE: DOOR) between June...
29. März 2026 19:28 ET | Quelle: The Rosen Law Firm PA

ROSEN, THE FIRST FILING FIRM, Encourages Franklin BSP Realty Trust, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FBRT

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Franklin BSP Realty Trust, Inc. (NYSE: FBRT) between...
29. März 2026 18:16 ET | Quelle: Alkane Resources Limited

Alkane Executes $110 Million Revolving Credit Facility

Alkane Executes $110 Million Revolving Credit Facility
29. März 2026 12:40 ET | Quelle: Robbins Geller Rudman & Dowd LLP

INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - RGRD Law

Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.

Vorherige Seite

Nächste Seite